Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure
- PMID: 16959756
- DOI: 10.1177/1089253206291150
Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure
Abstract
Despite the recent introduction of new therapeutic approaches to treat heart failure, mortality from heart failure remains high, and patients still frequently experience progression of contractile dysfunction and ongoing left ventricular enlargement. Therefore, new treatments are needed for heart failure that work independently of mechanisms already targeted. Emerging evidence suggests that the failure of the myocardium in heart failure is affected by alterations in the energy substrate metabolism. In particular, there is now evidence that in the failing heart, shifting metabolism away from a preference for fatty acids toward more carbohydrate oxidation can improve contractile function and slow the progression of pump failure.
Similar articles
-
Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.Int J Clin Pract. 2007 Apr;61(4):603-10. doi: 10.1111/j.1742-1241.2006.01280.x. Int J Clin Pract. 2007. PMID: 17394434 Review.
-
[Metabolic therapy for heart failure].Recenti Prog Med. 2014 Jul-Aug;105(7-8):288-94. doi: 10.1701/1574.17114. Recenti Prog Med. 2014. PMID: 25072544 Review. Italian.
-
Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?Coron Artery Dis. 2001 Feb;12 Suppl 1:S8-11. Coron Artery Dis. 2001. PMID: 11286307 Review.
-
Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.Biomed Pharmacother. 2010 Mar;64(3):203-7. doi: 10.1016/j.biopha.2009.10.002. Epub 2009 Nov 13. Biomed Pharmacother. 2010. PMID: 19954925 Review.
-
Myocardial substrate metabolism in the normal and failing heart.Physiol Rev. 2005 Jul;85(3):1093-129. doi: 10.1152/physrev.00006.2004. Physiol Rev. 2005. PMID: 15987803 Review.
Cited by
-
Metabolic imaging using PET.Eur J Nucl Med Mol Imaging. 2007 Jun;34 Suppl 1:S49-61. doi: 10.1007/s00259-007-0440-3. Epub 2007 May 5. Eur J Nucl Med Mol Imaging. 2007. PMID: 17486339 Review.
-
Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance.Antioxid Redox Signal. 2016 Aug 1;25(4):208-16. doi: 10.1089/ars.2016.6696. Epub 2016 May 4. Antioxid Redox Signal. 2016. PMID: 26983586 Free PMC article. Review.
-
Effect of perioperative glucose-insulin-potassium infusions on mortality and atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis.Can J Cardiol. 2010 Jun-Jul;26(6):178-84. doi: 10.1016/s0828-282x(10)70394-9. Can J Cardiol. 2010. PMID: 20548978 Free PMC article. Review.
-
Modulating carnitine levels by targeting its biosynthesis pathway - selective inhibition of γ-butyrobetaine hydroxylase.Chem Sci. 2014 May 1;5(5):1765-1771. doi: 10.1039/C4SC00020J. Chem Sci. 2014. PMID: 26682037 Free PMC article.
-
Cellular and molecular mechanisms of metformin: an overview.Clin Sci (Lond). 2012 Mar;122(6):253-70. doi: 10.1042/CS20110386. Clin Sci (Lond). 2012. PMID: 22117616 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
